SGShiona K. Glass-Kaastra

Shiona K. Glass-Kaastra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shiona K. Glass-Kaastra has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Durda Slavic

    Department of Population Medicine (Glass-Kaastra, Pearl, Reid-Smith, McEwen) and Department of Pathobiology (Reid-Smith), University of Guelph, 50 Stone Road East, Guelph, Ontario N1G 2W1; Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, 160 Research Lane, Guelph, Ontario N1G B52 (Reid-Smith); Animal Health Laboratory, University of Guelph, 419 Gordon Street, Guelph, Ontario N1G 2W1 (McEwen, Slavic, Fairles)

    3 shared publications
  • Jim Fairles

    Department of Population Medicine (Glass-Kaastra, Pearl, Reid-Smith, McEwen) and Department of Pathobiology (Reid-Smith), University of Guelph, 50 Stone Road East, Guelph, Ontario N1G 2W1; Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, 160 Research Lane, Guelph, Ontario N1G B52 (Reid-Smith); Animal Health Laboratory, University of Guelph, 419 Gordon Street, Guelph, Ontario N1G 2W1 (McEwen, Slavic, Fairles)

    3 shared publications
  • Beverly J. McEwen

    University of Guelph

    2 shared publications
  • Beverly McEwen

    Department of Population Medicine (Glass-Kaastra, Pearl, Reid-Smith, McEwen) and Department of Pathobiology (Reid-Smith), University of Guelph, 50 Stone Road East, Guelph, Ontario N1G 2W1; Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, 160 Research Lane, Guelph, Ontario N1G B52 (Reid-Smith); Animal Health Laboratory, University of Guelph, 419 Gordon Street, Guelph, Ontario N1G 2W1 (McEwen, Slavic, Fairles)

    2 shared publications
  • David L Pearl

    Department of Population Medicine (Glass-Kaastra, Pearl, Reid-Smith, McEwen) and Department of Pathobiology (Reid-Smith), University of Guelph, 50 Stone Road East, Guelph, Ontario N1G 2W1; Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, 160 Research Lane, Guelph, Ontario N1G B52 (Reid-Smith); Animal Health Laboratory, University of Guelph, 419 Gordon Street, Guelph, Ontario N1G 2W1 (McEwen, Slavic, Fairles)

    2 shared publications
  • David L. Pearl

    Department of Population Medicine , University of Guelph , Guelph, Ontario , Canada

    2 shared publications

Latest Publications

    • 1 October 2014
      • Vol. 78  (4) , 241-9

    Surveillance of antimicrobial resistance in clinical isolates of Pasteurella multocida and Streptococcus suis from Ontario swine.

    by Shiona K Glass-Kaastra, David L Pearl, Richard J Reid-Smith, Beverly McEwen, Durda Slavic, Jim Fairles, Scott A McEwen

    Susceptibility results for Pasteurella multocida and Streptococcus suis isolated from swine clinical samples were obtained from January 1998 to October 2010 from the Animal Health Laboratory at the University of Guelph, Guelph, Ontario, and used to describe variation in antimicrobial resistance (AMR) to 4 drugs of importance in the Ontario swine industry: ampicillin, tetracycline, tiamulin, and trimethoprim-sulfamethoxazole. Four temporal data-analysis options were used: visualization of trends in 12-month rolling averages, logistic-regression modeling, temporal-scan statistics, and a scan with the "What's strange about recent events?" (WSARE) algorithm. The AMR trends varied among the antimicrobial drugs for a single pathogen and between pathogens for a single antimicrobial, suggesting that pathogen-specific AMR surveillance may be preferable to indicator data. The 4 methods provided complementary and, at times, redundant results. The most appropriate combination of analysis methods for surveillance using these data included temporal-scan statistics with a visualization method (rolling-average or predicted-probability plots following logistic-regression models). The WSARE algorithm provided interesting results for quality control and has the potential to detect new resistance patterns; however, missing data created problems for displaying the results in a way that would be meaningful to all surveillance stakeholders.


    • 1 April 2014
      • Vol. 55  (4) , 341-8

    Antimicrobial susceptibility of Escherichia coli F4, Pasteurella multocida, and Streptococcus suis isolates from a diagnostic veterinary laboratory and recommendations for a surveillance system.

    by Shiona K Glass-Kaastra, David L Pearl, Richard J Reid-Smith, Beverly McEwen, Durda Slavic, Scott A McEwen, Jim Fairles

    Antimicrobial susceptibility data on Escherichia coli F4, Pasteurella multocida, and Streptococcus suis isolates from Ontario swine (January 1998 to October 2010) were acquired from a comprehensive diagnostic veterinary laboratory in Ontario, Canada. In relation to the possible development of a surveillance system for antimicrobial resistance, data were assessed for ease of management, completeness, consistency, and applicability for temporal and spatial statistical analyses. Limited farm location data precluded spatial analyses and missing demographic data limited their use as predictors within multivariable statistical models. Changes in the standard panel of antimicrobials used for susceptibility testing reduced the number of antimicrobials available for temporal analyses. Data consistency and quality could improve over time in this and similar diagnostic laboratory settings by encouraging complete reporting with sample submission and by modifying database systems to limit free-text data entry. These changes could make more statistical methods available for disease surveillance and cluster detection.


  • Open Access

    Longitudinal Surveillance of Outpatient Tetracycline, Sulfonamide-Trimethoprim and ‘Other’ Antimicrobial Use in Canada, 1995 to 2010

    by Shiona K Glass-Kaastra, Rita Finley, Jim Hutchinson, David M Patrick, Karl Weiss, John Conly

    INTRODUCTION: Monitoring the volume and patterns of use of antimicrobial agents is important in light of antimicrobial resistance.OBJECTIVE: To assess the use of three antimicrobial groups – tetracycline, sulfonamide-trimethoprim and ‘other’ antimicrobials – within Canadian provinces over time.METHODS: Prescription counts from 1995 to 2010 were acquired for the tetracycline and sulfonamide-trimethoprim groups of antimicrobials, and from 2001 to 2010 for the ‘other’ antimicrobial group. Linear mixed models were produced to assess differences among provinces and over time while accounting for repeated measurements. Prescription rate, defined daily dose per 1000 inhabitant-days and defined daily doses per prescription measures for the year 2009 were also compared with those reported by participating European Union countries to determine where Canadian provinces rank in terms of antimicrobial use among these countries.RESULTS: Prescribing of all three groups varied according to province and over time. Tetracycline and sulfonamide-trimethoprim group prescribing were significantly reduced over the study period, by 36% and 61%, respectively. Prescribing of the ‘other’ antimicrobial group increased in all provinces from 2001 to 2010 with the exception of Prince Edward Island, although by varying amounts (10% to 61% increases).DISCUSSION: The overall use of antimicrobials in Canada has dropped from 1995 to 2010, and the tetracycline and sulfonamide-trimethoprim groups have contributed to this decline. The use of the ‘other’ antimicrobials has increased, however. These results may suggest that switches are being made among these groups, particularly among the antimicrobials used to treat urinary tract infections.


  • Open Access

    Describing antimicrobial use and reported treatment efficacy in Ontario swine using the Ontario swine veterinary-based Surveillance program

    by Shiona K Glass-Kaastra, David L Pearl, Richard J Reid-Smith, Beverly McEwen, Scott A McEwen, Rocio Amezcua, Robert M Friendship

    The objective of this work was to retrospectively assess records received through the Ontario Swine Veterinary-based Surveillance program July 2007 – July 2009 to describe and assess relationships between reported treatment failure, antimicrobial use, diagnosis and body system affected.


  • Open Access

    A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06)

    by Shiona K. Glass, David L. Pearl, Scott A. McEwen, Rita Finley

    To assess potential risk factors among socioeconomic variables and the rate of influenza for the use of different fluoroquinolone antimicrobials in Canada, and to evaluate modelling fluoroquinolone-use data by two different outcome measures. Fluoroquinolone use was described monthly from 2000 to 2006 by two outcome measurements: defined daily doses and prescription counts. Multivariable linear and negative binomial models were produced with socioeconomic and influenza rate data. Significant socioeconomic predictors varied among the individual fluoroquinolone models, which may reflect the range of infections that are treated with fluoroquinolones. However, socioeconomic variables within the ciprofloxacin and levofloxacin models were similar, and indicated that use was highest in advantaged populations, depending on the measures being assessed. The rate of influenza was a significant predictor within models describing levofloxacin use and the defined daily dose model for ciprofloxacin use, after accounting for season. Influenza significantly interacted with the education variable in the levofloxacin defined daily dose model. Significant associations between levofloxacin use and influenza rates, after accounting for season, may suggest that levofloxacin was used to treat secondary bacterial infections or was prescribed inappropriately for seasonal viral respiratory tract infections. Yearly patterns of ciprofloxacin use show that prescribing practices changed; more ciprofloxacin prescriptions were dispensed towards the end of the study period, but for smaller doses or shorter treatment times. Associations with socioeconomic variables suggest that the fluoroquinolones ciprofloxacin and levofloxacin were more likely to be used in advantaged populations, probably due to the high cost of fluoroquinolone antimicrobials in comparison to the penicillin and macrolide groups.


  • Open Access

    Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006)

    by Shiona K. Glass, David L. Pearl, Scott A. McEwen, Rita Finley

    To assess provincial-level predictors among socioeconomic and influenza rate data for the use of different macrolide antimicrobials in Canada from 2000 to 2006. Multivariable models were developed to describe macrolide defined daily doses per capita. Use was highest during October to March for all macrolides. Investigated yearly and provincial patterns differed considerably among the macrolide agents. Associations with socioeconomic variables were similar between clarithromycin and erythromycin, while azithromycin consumption showed some differences in its association with these variables. Consistently, the rate of influenza was significantly associated with increased macrolide use. The influenza rate interacted with socioeconomic variables in some models; as the influenza rate increased, the greatest increase in demand for macrolides occurred in populations with high percentages of low-income individuals, high unemployment levels and low percentages of individuals with bachelor's degrees. The impact of associations among macrolide consumption, influenza and socioeconomic factors may reflect inappropriate use of these agents to treat viral infections and/or prescribing for secondary infections, and knowledge of the virus versus bacteria problem and accessibility of healthcare. Further research surrounding differences in access to antimicrobial prescriptions and treatment options between advantaged and disadvantaged populations is suggested to further understand the dynamics of antimicrobial use in Canada.